Enzymes |
Phospholipase A2
|
Anthozoa, Cubozoa, Schyphozoa, Hydrozoa |
Cytolytic, hemolytic, prey digestion |
13–45 |
[44,45,46] |
Metalloproteases |
Schyphozoa, Cubozoa, Anthozoa |
Cytotoxic, cytolytic, local tissue damage |
17–130 |
[12,14,47,48] |
Pore forming toxins (cytolysins) |
Actinoporins and actinoporin-like proteins |
Anthozoa, Hydrozoa |
Cytolytic, hemolytic, cardiovascular and respiratory arrest |
20 |
[49,50,51,52,53,54] |
Jellyfish Toxins |
Cubozoa |
Hemolytic, cardiotoxic, cytolytic, myotoxic, cutaneous inflammation |
42–46 |
[13,55,56,57] |
Hydralysins-related toxins |
Hydrozoa, Anthozoa |
Cytolytic, prey digestion |
27–31 |
[43,58,59,60] |
Membrane Attack Complex-Perforin |
Anthozoa |
Cytolytic, hemolytic |
60 |
[61,62] |
Neurotoxins |
NaTxs (type I-III) |
Anthozoa |
Neurotoxic, cardiotoxic, insecticide |
3–8 |
[63,64,65,66,67] |
KTxs (type I,III and IV,V KTxs) |
Anthozoa |
Neurotoxic, hypotensive, cardiotoxic, analgesic, antimicrobial, immunosuppressive, anti obesity |
3–4 |
[68,69,70,71,72,73,74,75] |
Kunitz peptides (type II KTxs) |
Anthozoa |
Paralytic, serine protease inhibitor |
6 |
[76,77,78,79] |
Small Cysteine-Rich Proteins (SCRiPs) and SCRiPs homologues |
Anthozoa |
Paralytic |
4.3–5.8 |
[80] |
ASIC Inhibitors |
Anthozoa |
Analgesic |
3 |
[81,82] |
TRPV1 Inhibitors |
Anthozoa |
Analgesic |
3 |
[83,84] |
Non-protein bioactive components |
Serotonin |
Hydrozoa, Anthozoa |
Vasodilation, sharp pain |
- |
[85] |
Histamine |
Anthozoa |
Vasodilation, sharp pain |
- |
[86,87] |
Bunodosine |
Anthozoa |
Analgesic |
- |
[88] |
Caissarone |
Anthozoa |
Adenosine receptor antagonist |
- |
[89] |